17-alpha-hydroxypregnenolone has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, Y; Nakamura, N; Nakano, K; Obayashi, H; Ohta, M; Tagawa, N | 1 |
| Sacerdote, AS | 1 |
2 other study(ies) available for 17-alpha-hydroxypregnenolone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Serum concentrations of delta 5-3 beta-hydroxysteroids in type 2 diabetes mellitus.
Topics: 17-alpha-Hydroxypregnenolone; Adult; Androstenediol; Dehydroepiandrosterone; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Pregnenolone; Statistics, Nonparametric | 2002 |
Adrenal androgens and NIDDM.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adult; Aged; Aged, 80 and over; Androgens; Cosyntropin; Dexamethasone; Diabetes Mellitus; Diabetes Mellitus, Type 2; Estrogens; Female; Humans; Hydroxyprogesterones; Male; Middle Aged; Obesity; Premenopause | 1995 |